Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 35 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04116541
- Conditions
- Malignant Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- INSTITUT DE CANCEROLOGIE DE L'OUEST Pays de Loire Angers, France
- Institut Bergonié Bordeaux, France
- Centre François Baclesse Caen, France
- Centre Léon Bérard Lyon, France
Recruiting
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
NCT06824363
- Conditions
- Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Malignant Solid Tumor, +2 more
- Locations
-
- Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States
NCT04145622
- Conditions
- Advanced Solid Tumor, Malignant Solid Tumor, Neoplasms
- Locations
-
- Cedars-Sinai Medical Center- Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Orlando, Florida, United States
- Florida Cancer Specialists Sarasota, Florida, United States
NCT05468359
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
- Locations
-
- Methodist Le Bonheur Healthcare Germantown, Tennessee, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT06171750
- Conditions
- Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
- Locations
-
- National Cancer Institute Bethesda, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Providence Cancer Institute Portland, Oregon, United States
- Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Recruiting
Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NCT06735144
- Conditions
- Malignant Solid Tumor
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT04151342
- Conditions
- Cancer, Cancer, Therapy-Related, Congenital Abnormalities, +11 more
- Locations
-
- Tom Baker Cancer Centre - University of Calgary - Alberta Health Services Calgary, Alberta, Canada
- Cross Cancer Institute, University of Alberta - Alberta Health Services Edmonton, Alberta, Canada
- BC Cancer Vancouver, British Columbia, Canada
- CancerCare Manitoba/University of Manitoba Winnipeg, Manitoba, Canada
NCT05629689
- Conditions
- Malignant Solid Tumor, Neoplasms, Oncology
- Locations
-
- Amsterdam UMC Amsterdam, Netherlands
- UMC Groningen Groningen, Netherlands
- Conditions
- Carcinoma, Epithelial Tumors, Malignant, Malignant Solid Tumor, +3 more
- Locations
-
- Vall d'Hebron Institute of Oncology Barcelona, Spain
Not Yet Recruiting
A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets
NCT07639905
- Conditions
- Malignant Solid Tumor
- Locations
-
- The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
Not Yet Recruiting
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NCT07136142
- Conditions
- Malignant Solid Tumor
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Tianjin Medical Unversity Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
NCT05727839
- Conditions
- Cutaneous Tumor, Malignant Solid Tumor, Neoplasms, +4 more
- Locations
-
- The George Washington Medical Faculty Associates Washington D.C., District of Columbia, United States
- Sun Yat-sen University Cancer Center Guangdong, Guangzhou, China
Completed
A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies
NCT03834662
- Conditions
- Malignant Solid Tumor
- Locations
-
- START Midwest Clinic Grand Rapids, Michigan, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Princess Margaret Cancer Centre Toronto, Canada
NCT01359982
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Moores University of California San Diego Cancer Center La Jolla, California, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Conditions
- Malignant Solid Tumor
- Locations
-
- The University of Kansas Clinical Research Center Site Number : 8400004 Fairway, Kansas, United States
- Massachusetts General Hospital Site Number : 8400001 Boston, Massachusetts, United States
- Dana Farber Cancer Institute Site Number : 8400101 Boston, Massachusetts, United States
- Duke University Medical Center Site Number : 8400008 Durham, North Carolina, United States
NCT02754141
- Conditions
- Malignant Solid Tumor
- Locations
-
- Local Institution - 0028 Chicago, Illinois, United States
- Local Institution - 0001 Baltimore, Maryland, United States
- Local Institution - 0022 Boston, Massachusetts, United States
- Local Institution - 0023 Buffalo, New York, United States
NCT02252211
- Conditions
- Malignant Solid Tumor, Metastatic EphA2 Positive Cancer
- Locations
-
- Austin Health Heidelberg, Victoria, Australia
NCT03551795
- Conditions
- Malignant Solid Tumor
- Locations
-
- Shanghai Public Health Clinical Center, Fudan University Shanghai, China
NCT01515306
- Conditions
- Malignant Solid Tumor
- Locations
-
- ImClone Investigational Site Ann Arbor, Michigan, United States
- ImClone Investigational Site Detroit, Michigan, United States
- ImClone Investigational Site New Brunswick, New Jersey, United States
- ImClone Investigational Site Cleveland, Ohio, United States
NCT03905720
- Conditions
- Agnosia, Malignant Solid Tumor, Neoplasms, +7 more
- Locations
-
- Zuckerberg San Francisco General Hospital San Francisco, California, United States
- University of California, San Francisco San Francisco, California, United States